Cannabinoid use increases need for higher sedation during endoscopy

SAN DIEGO — Baseline cannabinoid use associated with the need for increased sedation among patients who underwent endoscopy with endoscopist-directed conscious sedation, according to research presented at Digestive Disease Week.“Endoscopist-directed conscious sedation, or EDCS, is widely used for routine endoscopic procedures such as gastroscopy and colonoscopy. While efficient and cost-effective, EDCS can be limited by failure to achieve sufficient levels of sedation,” Yasmin Nasser, MD, PhD, assistant professor of medicine at the University of Calgary, said. “WithRead More

Related Articles